Evidence map›Paper›PMID 30515697›Full record

ArticleMolecular biology reports2019

Effects of JUN and NFE2L2 knockdown on oxidative status and NFE2L2/AP-1 targets expression in HeLa cells in basal conditions and upon sub-lethal hydrogen peroxide treatment.

Anna A Belanova, Victor K Chmykhalo, Maxim S Makarenko, Olga V Lyangasova, Maria M Belousova, Anzhela A Aleksandrova, Peter V Zolotukhin

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular biology reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Nanocomposites for X-Ray Photodynamic Therapy.International journal of molecular sciences · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Anna A BelanovaBiomedical Innovations LLC, 112 Mechnikova St., Rostov-on-Don, Russia, 344013.
Victor K ChmykhaloBiomedical Innovations LLC, 112 Mechnikova St., Rostov-on-Don, Russia, 344013.
Maxim S MakarenkoAcademy of Biology and Biotechnology, Southern Federal University, 194/1 Stachki Av., Rostov-on-Don, Russia, 344090.
Olga V LyangasovaAcademy of Biology and Biotechnology, Southern Federal University, 194/1 Stachki Av., Rostov-on-Don, Russia, 344090.
Maria M BelousovaDepartment of English Language for Natural Sciences Faculties, Southern Federal University, 5 Sorge St., Rostov-on-Don, Russia, 344090.
Anzhela A AleksandrovaAcademy of Biology and Biotechnology, Southern Federal University, 194/1 Stachki Av., Rostov-on-Don, Russia, 344090.
Peter V ZolotukhinBiomedical Innovations LLC, 112 Mechnikova St., Rostov-on-Don, Russia, 344013. pvzolotuhin@sfedu.ru.ORCID http://orcid.org/0000-0002-7747-8278
Southern Federal University · RU

Funding

Russian Ministry for Science and Education 6.6762.2017
6 · The paper itself

Abstract

Although NFE2L2 transcription factor is considered to make the most significant contribution to the NFE2L2/AP-1-pathway-dependent antioxidants regulation in the human cell, AP-1 has the potential to provide significant backup and even play an equal role in the cell. Considering this, the present study is focused on revealing how JUN, an AP-1 component, and NFE2L2 contribute to regulation of four target genes containing AREs with embedded TREs-SQSTM1, FTH1, HMOX1 and CBR3 and to cellular oxidative status in general in basal conditions and under pro-oxidative influence. NFE2L2 and JUN were down-regulated in HeLa cells using siRNA-mediated knockdown approach. These cells were subsequently exposed to 400 µM hydrogen peroxide in the medium or equal volume of sterile water. They revealed some evidence of both backup functioning and competing between the two factors. Importantly, JUN demonstrated a high level of participation (inc. as a negative regulator) in functioning of the classic NFE2L2 targets and in cellular oxidative status establishment in general. One of the key findings was a dramatic increase in JUN expression following NFE2L2 knockdown in basal conditions. The both AP-1 and NFE2L2 sub-pathways equally determine the outcome of the NFE2L2/AP-1 pathway activation induced by various stimuli, and the outcome is stimulus type- and stimulus-intensity-specific and results from either of the two eventually dominating sub-pathways.

Indexed as

AntioxidantsDown-RegulationEpithelial CellsGene Expression RegulationGene Knockdown TechniquesHeLa CellsHeme Oxygenase-1HumansHydrogen PeroxideNF-E2-Related Factor 2Oxidation-ReductionOxidative StressProto-Oncogene Proteins c-junTranscription Factor AP-1AntioxidantsHeme Oxygenase-1Hydrogen PeroxideNFE2L2 protein, humanNF-E2-Related Factor 2Proto-Oncogene Proteins c-junTranscription Factor AP-1Antioxidant signalingAP-1NFE2L2NRF2Oxidative status

Identifiers

PMID30515697
OpenAlexW2903358934

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.